Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Topical Cetirizine in Androgenetic Alopecia in Females [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for topical cetirizine in women with androgenetic alopecia, study phases 2 and 3, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine (cetirizine)

Snippet

Sponsor: Cairo University | Conditions: Androgenetic Alopecia | Phase 2, Phase 3 | Status: COMPLETED